Investigation in Progress — No Complaint Filed Yet
BG&G is actively investigating potential securities fraud claims against Avid Bioservices, Inc.. If a complaint is filed, this page will be updated. Investors are encouraged to contact us now to preserve their rights.
Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Avid Bioservices, Inc. (“Avid”) (NASDAQ: CDMO) and GHO Capital Partners and Ampersand Capital Partners. Investors who purchased Avid and continue to hold to the present are encouraged to obtain additional information and assist the investigation.
Investigation Details
The investigation concerns whether Avid’s board of directors breached its fiduciary duties and failed to provide relevant information to its shareholders before the merger.
The Company announced that it will be acquired by GHO Capital Partners and Ampersand Capital Partners in a $1.1 billion all-cash transaction.
What’s Next?
If you are aware of any facts relating to this investigation or purchased Avid shares, you can assist this investigation. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660
CDMO — Stock Performance
About Bronstein, Gewirtz & Grossman, LLC
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
“Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace.”